[ad_1]
Studies are underway to find a cure for the corona virus, which infects more than 3 million people worldwide and kills more than 225,000 people. Countries compete both over time and with each other to develop vaccines and drugs against the virus.
According to the news in Sözcü, One of the most mentioned institutions in this process is the University of Oxford, England. Explaining that they began humanized experiments on the vaccine prototype they developed, experts said they plan to get the first results at this stage in mid-June.
It will be obvious in June
Teacher the names on the computer. John Bell said: “This is still an ongoing program. We need to see it work in people. Our team has vaccinated hundreds of people. We hope to receive a positive signal in mid-June. “
Bell also announced a major development for the public. He announced that Oxford has partnered with Cambridge-based pharmaceutical giant AstraZeneca to participate in the mass production process of vaccines.
“If we get approval, we don’t want to go back and find out how to produce on a large scale. We want to make sure that the rest of the world is ready to produce it. “
100 MILLION DOSE AT THE END OF THE YEAR
Bell said they agreed with the company that they are not for profit within the scope of the project, but emphasized that only the costs will be covered and that the vaccine will be available to low- and middle-income countries.
AstraZeneca official Pascal Soriot said his goal is to produce 100 million doses of the vaccine by the end of the year if approval is received.
